SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 109 filers reported holding SEELOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,000 | +100.0% | 1,699 | -10.5% | 0.00% | – |
| Q1 2023 | $1,000 | -50.0% | 1,899 | -24.7% | 0.00% | – |
| Q4 2022 | $2,000 | -33.3% | 2,521 | -1.2% | 0.00% | – |
| Q3 2022 | $3,000 | – | 2,551 | +433.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 478 | -92.1% | 0.00% | – |
| Q1 2022 | $5,000 | -86.1% | 6,036 | -73.3% | 0.00% | – |
| Q4 2021 | $36,000 | +24.1% | 22,601 | +89.9% | 0.00% | – |
| Q3 2021 | $29,000 | +107.1% | 11,903 | +128.2% | 0.00% | – |
| Q2 2021 | $14,000 | -56.2% | 5,217 | -17.8% | 0.00% | – |
| Q1 2021 | $32,000 | – | 6,345 | +634400.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | -99.8% | 0.00% | – |
| Q2 2020 | $0 | – | 449 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 449 | -1.5% | 0.00% | – |
| Q3 2019 | $0 | – | 456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 508,000 | $249,000 | 0.10% |
| 1492 Capital Management LLC | 150,000 | $74,000 | 0.09% |
| Uniplan Investment Counsel, Inc. | 2,069,121 | $1,014,000 | 0.08% |
| ARDSLEY ADVISORY PARTNERS LP | 70,000 | $34,000 | 0.01% |
| Spark Investment Management LLC | 35,210 | $17,000 | 0.01% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 191,000 | $94,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $15,000 | 0.00% |
| Procyon Advisors, LLC | 2,500 | $1,000 | 0.00% |
| Renaissance Technologies | 1,078,379 | $529,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |